New insulin glargine 300U/ml in Type 2 diabetes using basal plus meal-time insulin: sustained glycaemic control and less hypoglycaemia compared with glargine 100U/ml (EDITION 1)

被引：0
|
作者：
Home, P. D. [1 ]
Yki-Jarvinen, H. [2 ]
Bolli, G. B. [3 ]
Cissokho, S. [4 ]
Riddle, M. C. [5 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Univ Helsinki, Helsinki, Finland
[3] Univ Perugia, I-06100 Perugia, Italy
[4] Keyrus Biopharma, Levallois Perret, France
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
DIABETIC MEDICINE | 2015年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P155
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] New insulin glargine 300U/ml in people with Type 2 diabetes using basal insulin plus oral glucose lowering drugs compared with glargine 100U/ml (EDITION 2): less nocturnal hypoglycaemia and weight gain
    Home, P. D.
    Riddle, M. C.
    Bergenstal, R. M.
    Bolli, G. B.
    Wardecki, M.
    Maroccia, M.
    Yki-Jarvinen, H.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 79
  • [2] New insulin glargine 300U/ml (Gla-300): glycaemic control and hypoglycaemia in insulin-naive people with Type 2 diabetes compared with glargine 100U/ml (Gla-100)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    [J]. DIABETIC MEDICINE, 2015, 32 : 78 - 78
  • [3] Glycaemic control and hypoglycaemia during 12months of randomized treatment with insulin glargine 300U/mL versus glargine 100U/mL in people with type 1 diabetes (EDITION 4)
    Home, Philip D.
    Bergenstal, Richard M.
    Bolli, Geremia B.
    Ziemen, Monika
    Rojeski, Maria
    Espinasse, Melanie
    Riddle, Matthew C.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 121 - 128
  • [4] Sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml vs 100 U/ml: 1-year results in type 2 diabetes with basal and mealtime insulin (EDITION 1)
    Riddle, M. C.
    Yki-Jaervinen, H.
    Bolli, G. B.
    Ziemen, M.
    Muehlen-Bartmer, I.
    Cissokho, S.
    Home, P. D.
    [J]. DIABETOLOGIA, 2014, 57 : S402 - S402
  • [5] Glycaemic variability and risk for hypoglycaemia on insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes
    Kovatchev, B.
    Meng, Z.
    Breton, M.
    Leroy, B.
    Cali, A.
    Perfetti, R.
    [J]. DIABETOLOGIA, 2017, 60 : S36 - S37
  • [6] One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
    Riddle, M. C.
    Yki-Jaervinen, H.
    Bolli, G. B.
    Ziemen, M.
    Muehlen-Bartmer, I.
    Cissokho, S.
    Home, P. D.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 835 - 842
  • [7] Sustained glycaemic control and less hypoglycaemia over 1y with new insulin glargine 300 U/ml vs glargine 100 U/ml in Japanese type 2 diabetes mellitus people on basal insulin plus OAD(s) (EDITION JP 2)
    Terauchi, Y.
    Koyama, M.
    Cheng, X.
    Sumi, M.
    Hirose, T.
    [J]. DIABETOLOGIA, 2015, 58 : S463 - S463
  • [8] Sustained glycaemic control and less nocturnal hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml over 1 year in Japanese people with type 1 diabetes mellitus
    Matsuhisa, M.
    Koyama, M.
    Cheng, X.
    Sumi, M.
    Hirose, T.
    [J]. DIABETOLOGIA, 2015, 58 : S2 - S3
  • [9] Glycaemic control and hypoglycaemia with new insulin glargine 300 U/mL in people with type 1 diabetes (EDITION 4)
    Home, P. D.
    Bergenstal, R. M.
    Riddle, M. C.
    Ziemen, M.
    Rojeski, M.
    Espinasse, M.
    Bolli, G. B.
    [J]. DIABETOLOGIA, 2014, 57 : S69 - S70
  • [10] Efficacy and Safety of Insulin Glargine 300U/mL versus 100U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
    Vargas-Uricoechea, Hernando
    [J]. JOURNAL OF DIABETES RESEARCH, 2018, 2018
12345